Author:
Pham James P.,Frew John W.
Publisher
Springer Nature Switzerland
Reference84 articles.
1. Abbas M, Robalo Nunes T, Martischang R, et al. Nosocomial transmission and outbreaks of coronavirus disease 2019: the need to protect both patients and healthcare workers. Antimicrob Resist Infect Control. 2021;10:1–13.
2. Adams L, Nakafero G, Grainge MJ, et al. Is vaccination against Covid-19 associated with psoriasis or eczema flare? Self-controlled case series analysis using data from the clinical practice research datalink (aurum). Br J Dermatol. 2022;188:297.
3. Alexander JL, Kennedy NA, Ibraheim H, et al. COVID-19 vaccine-induced antibody responses in immunosuppressed patients with inflammatory bowel disease (VIP): a multicentre, prospective, case-control study. Lancet Gastroenterol Hepatol. 2022;7:342–52.
4. Al-Janabi A, Ra A, Littlewood Z, et al. The effect of immunomodulators on seroconversion to BNT162b2 and AZD1222 vaccines in patients with immune-mediated inflammatory diseases: a prospective cohort study. Br J Dermatol. 2022;188:ljac109.
5. American Academy of Dermatology. Guidance on the use of immunosuppressive agents. https://www.aad.org/member/practice/coronavirus/clinical-guidance/biologics. Accessed 14 Dec 2022.